BA has extended its pullback from August highs — now down 5.4% on the week to $211.08 — and the options market has followed the price lower with its most defensive posture of the past year.
The clearest signal this week is in options. The put/call ratio has climbed to 0.95, nearly three standard deviations above its 20-day average of 0.86 — a z-score of 2.86, the highest in the data window and close to the 52-week peak of 1.02. That's a meaningful deterioration from the 0.87 PCR flagged in last week's note, and it marks a clean escalation: each day this week the ratio has pushed higher, reaching 0.94 on Monday and 0.95 by Tuesday. Demand for downside protection has accelerated alongside the price decline, not levelled off. Short interest, by contrast, has not turned aggressive. Shares short have risen to 2.05% of the free float — up about 6.8% on the week and 12% over the past month — but that remains a low absolute level. Borrow conditions are entirely unconstraining: availability is at nearly 6,942%, meaning there are roughly 69 shares available for every one currently lent out. Cost to borrow is 0.41%. The lending market reflects no stress whatsoever, leaving options as the sole source of this week's hedging signal.
The Street remains firmly in Boeing's corner, even as the stock retreats. The analyst consensus is a strong buy, with 18 buy ratings against just 5 holds and no sells. Recent moves have been directionally positive: BNP Paribas flipped from Underperform to Outperform in early August with a $300 target, and Argus Research upgraded to Buy with a $265 target on August 11. JP Morgan raised its target to $290 after the July earnings print, though RBC trimmed slightly to $265. Mean target across the group sits around $270–$290, implying 25–35% upside from current levels. Factor scores reinforce the bull case in places that matter: EPS momentum over 90 days ranks in the 98th percentile, EPS surprise in the 93rd, and analyst recommendation divergence at the 99th — meaning Boeing's consensus is unusually bullish relative to the broader universe. The drag is valuation. A trailing PE above 106 and price-to-book near 18 leave Boeing priced for significant earnings recovery, and the forward EPS picture (ranking in just the 6th percentile for year-on-year increase) suggests that recovery is still more anticipated than delivered.
The institutional ownership picture adds one interesting detail. Capital Research and Management added nearly 10 million shares as of July 31 — the largest change among the top 15 holders — bringing their stake to just over 5% of shares. BlackRock also added roughly 3 million shares over the same period. Both moves predate the current week's selloff, but they reflect meaningful conviction from two of the larger active owners at levels close to where the stock is trading now. On the insider side, CEO Kelly Ortberg sold 6,232 shares at $234 on August 10 and CFO Jay Malave sold 4,205 shares at $228 on August 17 — both at prices well above where the stock sits today. The trades carry low significance scores and are likely routine, but they do mean both the CEO and CFO were net sellers at prices the market has since moved away from.
The most recent earnings print, from late July, was modestly positive on the day (+1.2%) and strongly positive over the following five days (+12.1%) — a pattern that set the context for the August rally that is now unwinding. Q3 results are scheduled for October 21, leaving roughly eight weeks of positioning ahead of the next real data event.
With the PCR now at its highest reading in a year, short interest quietly building, and the stock giving back almost all of its post-earnings five-day gain, the question heading into next week is whether options hedging reflects a temporary air pocket or the start of a more sustained re-rating lower ahead of the October print.
See the live data behind this article on ORTEX.
Open BA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
